Skip to main content
TELEFLEX INC logo

TELEFLEX INC — Investor Relations & Filings

Ticker · TFX ISIN · US8793691069 LEI · UUL85LWXB4NGSWWXIQ25 US Manufacturing
Filings indexed 1,749 across all filing types
Latest filing 2013-12-05 Regulatory Filings
Country US United States of America
Listing US TFX

Teleflex Inc. is a global provider of medical technologies that designs, develops, manufactures, and supplies specialty medical devices. The company's products are primarily single-use devices for a range of procedures in critical care and surgery. Its portfolio serves various medical specialties, including anesthesia, emergency medicine, interventional cardiology and radiology, interventional urology, and surgical applications. A key focus is on purpose-driven innovation to improve the health and quality of people's lives. Additionally, Teleflex offers original equipment manufacturing (OEM) services, supporting other medical device companies in design and development.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2013
Regulatory Filings
2013-12-05 English
PRIMARY DOCUMENT
Director's Dealing
2013-11-08 English
LIVE FILING
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically details the departure and retirement plans of a senior executive, Laurence G. Miller, including changes in his role and compensation arrangements. This fits the description of announcements related to changes in the company's board of directors or senior management. Therefore, the document is best classified under Board/Management Information (MANG). The document length is 3628 characters, which is typical for an 8-K filing and not a full annual or quarterly report. No financial statements or earnings data are included, so it is not an earnings release or interim report. Hence, the classification is MANG with high confidence.
2013-11-01 English
FORM 10-Q
Interim / Quarterly Report Q3 2013
2013-10-30 English
FORM 8-K
Investor Presentation Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated October 30, 2013. It references a conference call held to discuss financial results for the quarter ended September 29, 2013, and includes a slide presentation as Exhibit 99.1. The text explicitly states that the slide presentation was made available in advance of the call and is furnished as an exhibit. The content is primarily about the investor conference call and the related presentation slides, not the full transcript or detailed financial report. Therefore, this document is best classified as an Investor Presentation (IP). The document length is 3061 characters, which is consistent with a brief report furnishing a presentation rather than a full financial report or transcript.
2013-10-30 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text includes Item 2.02, which reports the results of operations and financial condition for the quarter ended September 29, 2013, and references a press release with financial results. It also includes Item 7.01, announcing a definitive agreement to acquire Vidacare Corporation, referencing another press release. The document is not a full financial report but a current report announcing financial results and a material acquisition agreement. The presence of press releases as exhibits and the nature of the content indicate this is a regulatory filing reporting significant events rather than a full earnings release or merger filing. Therefore, the best classification is Regulatory Filings (RNS).
2013-10-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.